Effects of Receipt of Guideline-Recommended Care on Onset of Diabetic Retinopathy and Its Progression

Ophthalmology

Volumn 116, Issue 8, 2009, Pages

  Sloan, Frank A ^a   Grossman, Daniel S ^a   Lee, Paul P ^b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; LIPID;

AGED; ARTICLE; BLINDNESS; COHORT ANALYSIS; COMMUNITY CARE; DIABETES MELLITUS; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE COURSE; EYE EXAMINATION; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MALE; MEDICAL SPECIALIST; MEDICARE; ONSET AGE; OPHTHALMOLOGY; OPTOMETRY; OUTCOME ASSESSMENT; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; URINALYSIS; VISION; VISUAL AID; VISUAL DISORDER;

EID: 67949089853     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.03.010     Document Type: Article

References (35)

1. Cowie C.C., Rust K.F., Byrd-Holt D.D., et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 29 (2006) 1263-1268
2. King H., Aubert R.E., and Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21 (1998) 1414-1431
3. Wild S., Roglic G., Green A., et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
4. Kohner E.M., Aldington S.J., Stratton I.M., et al., United Kingdom Prospective Diabetes Study. United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 116 (1998) 297-303
5. Klein R., and Klein B.E. Vision disorders in diabetes. National Diabetes Data Group. Diabetes in America. 2nd ed. (1995), National Institutes of Health, Bethesda, MD 293-338. http://diabetes.niddk.nih.gov/dm/pubs/America/pdf/chapter14.pdf Accessed December 3, 2008
6. Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 122 (2004) 552-563
7. Salm M., Belsky D., and Sloan F.A. Trends in cost of major eye diseases to Medicare, 1991 to 2000. Am J Ophthalmol 142 (2006) 976-982
8. Williams R., Van Gaal L., Lucioni C., and CODE-2 Advisory Board. Assessing the impact of complications on the costs of type II diabetes. Diabetologia 45 (2002) S13-S17
9. Lee P.P., Feldman Z.W., Ostermann J., et al. Longitudinal rates of annual eye examinations of persons with diabetes and chronic eye diseases. Ophthalmology 110 (2003) 1952-1959
10. Saaddine J.B., Engelgau M.M., Beckles G.L., et al. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med 136 (2002) 565-574
11. Sloan F.A., Bethel M.A., Lee P.P., et al. Adherence to guidelines and its effects on hospitalizations with complications of type 2 diabetes. Rev Diabet Stud 1 (2004) 29-38
12. Koro C.E., Bowlin S.J., Bourgeois N., and Fedder D.O. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care 27 (2004) 17-20
13. McClellan W.M., Millman L., Presley R., et al. Improved diabetes care by primary care physicians: results of a group-randomized evaluation of the Medicare Health Care Quality Improvement Program (HCQIP). J Clin Epidemiol 56 (2003) 1210-1217
14. McGlynn E.A., Asch S.M., Adams J., et al. The quality of health care delivered to adults in the United States. N Engl J Med 348 (2003) 2635-2645
15. Zoorob R.J., and Hagen M.D. Guidelines on the care of diabetic nephropathy, retinopathy and foot disease. Am Fam Physician 56 (1997) 2021-2028
16. Hoerger T.J., Gregg E.W., Segel J.E., and Saaddine J.B. Is glycemic control improving in U.S. adults?. Diabetes Care 31 (2008) 81-86
17. D'Agostino Jr. R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281
18. Rosenbaum P.R., and Rubin D.B. The central role of the propensity score in observational studies for causal effects. Biometrika 70 (1983) 41-55
19. Austin P.C. Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement. J Thorac Cardiovasc Surg 134 (2007) 1128-1135
20. Normand S.L., Landrum M.B., Guadagnoli E., et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol 54 (2001) 387-398
21. Austin P.C., Grootendorst P., and Anderson G.M. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med 26 (2007) 734-753
22. Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Ophthalmology 102 (1995) 647-661
23. Tikellis G., Wang S., Wong N., et al. Poor metabolic and blood pressure control in patients with diabetic retinopathy attending a tertiary ophthalmic hospital in Australia. Diabetes Res Clin Pract 80 (2008) 208-212
24. Schoenfeld E.R., Greene J.M., Wu S.Y., and Leske M.C. Patterns of adherence to diabetes vision care guidelines: baseline findings from the Diabetic Retinopathy Awareness Program. Ophthalmology 108 (2001) 563-571
25. Martin T.L., Selby J.V., and Zhang D. Physician and patient prevention practices in NIDDM in a large urban managed-care organization. Diabetes Care 18 (1995) 1124-1132
26. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy: ETDRS report number 9. Ophthalmology 98 suppl (1991) 766-785
27. Dallo F.J., and Weller S.C. Effectiveness of diabetes mellitus screening recommendations. Proc Natl Acad Sci U S A 100 (2003) 10574-10579
28. Singer D.E., Nathan D.M., Fogel H.A., and Schachat A.P. Screening for diabetic retinopathy. Ann Intern Med 116 (1992) 660-671
29. Nathan D.M. Long-term complications of diabetes mellitus. N Engl J Med 328 (1993) 1676-1685
30. O'Brien J.A., Shomphe L.A., Kavanagh P.L., et al. Direct medical costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care 21 (1998) 1122-1128
31. Javitt J.C., and Aiello L.P. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 124 (1996) 164-169
32. Javitt J.C., Aiello L.P., Chiang Y.P., et al. Preventive eye care in people with diabetes is cost-saving to the federal government: implications for health-care reform. Diabetes Care 17 (1994) 909-917
33. Coleman A.L., and Morgenstern H. Use of insurance claims databases to evaluate the outcomes of ophthalmic surgery. Surv Ophthalmol 42 (1997) 271-278
34. Javitt J.C., Zhou Z., Maguire M.G., et al. Incidence of exudative age-related macular degeneration among elderly Americans. Ophthalmology 110 (2003) 1534-1539
35. Lee P.P., Feldman Z.W., Ostermann J., et al. Longitudinal prevalence of major eye diseases. Arch Ophthalmol 121 (2003) 1303-1310